Akso Health Group: 20-F filed 2019-07-31

Name: Akso Health Group: 20-F filed 2019-07-31
Creator: Akso Health Group

What Akso Health Group reported in its annual report (foreign private issuer) filed 2019-07-31 (fiscal FY 2019): 41 published measures, 105 facts as tagged in accession 0001104659-19-042798.

This filing

Form: 20-F (annual report (foreign private issuer))
Filed: 2019-07-31
Fiscal period: fiscal FY 2019
Accession: 0001104659-19-042798 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Akso Health Group filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2019-03-31	173,255,842	USD
At 2018-03-31	163,889,852	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2019-03-31	46,752,684	USD
At 2018-03-31	23,846,783	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2019-03-31	126,503,158	USD
At 2018-03-31	140,043,069	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2019-03-31	57,372,128	USD
At 2018-03-31	132,622,467	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	5,532,581	USD	365
2017-04-01 to 2018-03-31	65,481,973	USD	365
2016-04-01 to 2017-03-31	8,570,864	USD	365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	-1,731,075	USD	365
2017-04-01 to 2018-03-31	87,723,007	USD	365
2016-04-01 to 2017-03-31	8,189,744	USD	365

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	61,330,504	USD	365
2017-04-01 to 2018-03-31	107,257,841	USD	365
2016-04-01 to 2017-03-31	22,920,543	USD	365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	-29,377	USD	365
2017-04-01 to 2018-03-31	47,516,258	USD	365
2016-04-01 to 2017-03-31	4,288,646	USD	365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	-68,106,557	USD	365
2017-04-01 to 2018-03-31	-27,623,791	USD	365
2016-04-01 to 2017-03-31	-287,765	USD	365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2019-03-31	69,768,756	USD
At 2018-03-31	77,241,073	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	48,693,162	shares	365
2017-04-01 to 2018-03-31	44,977,780	shares	365
2016-04-01 to 2017-03-31	42,331,200	shares	365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	52,912,826	shares	365
2017-04-01 to 2018-03-31	47,656,263	shares	365
2016-04-01 to 2017-03-31	42,331,200	shares	365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	0.11	USD/shares	365
2017-04-01 to 2018-03-31	1.46	USD/shares	365
2016-04-01 to 2017-03-31	0.2	USD/shares	365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	0.1	USD/shares	365
2017-04-01 to 2018-03-31	1.37	USD/shares	365
2016-04-01 to 2017-03-31	0.2	USD/shares	365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	1,872,672	USD	365
2017-04-01 to 2018-03-31	11,025,690	USD	365
2016-04-01 to 2017-03-31	1,522,211	USD	365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2019-03-31	1,253,723	USD
At 2018-03-31	767,087	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	6,585,386	USD	365
2017-04-01 to 2018-03-31	1,828,868	USD	365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	5,097,768	USD	365
2017-04-01 to 2018-03-31	75,875,438	USD	365
2016-04-01 to 2017-03-31	9,913,546	USD	365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2019-03-31	97,680,645	USD
At 2018-03-31	163,122,765	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2019-03-31	26,562,726	USD
At 2018-03-31	23,846,783	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2019-03-31	140,639	USD
At 2018-03-31	0	USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	1,320,468	USD	365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	1,151,371	USD	365
2017-04-01 to 2018-03-31	2,816,991	USD	365
2016-04-01 to 2017-03-31	1,567,738	USD	365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2019-03-31	49,204,083	shares
At 2018-03-31	47,958,550	shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

Period	Value	Unit
At 2019-03-31	57,372,128	USD
At 2018-03-31	132,622,467	USD
At 2017-03-31	19,232,275	USD
At 2016-03-31	7,818,936	USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2019-03-31	59,806,865	USD
At 2018-03-31	58,417,971	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2019-03-31	-1,756,958	USD
At 2018-03-31	4,379,229	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit
At 2019-03-31	126,503,158	USD
At 2018-03-31	140,043,069	USD
At 2017-03-31	23,504,356	USD
At 2016-03-31	14,011,957	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2019-03-31	1,999,272	USD
At 2018-03-31	1,131,401	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2019-03-31	745,549	USD
At 2018-03-31	364,314	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2019-03-31	3,334,965	USD
At 2018-03-31	1,248,562	USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

Period	Value	Unit	Days
At 2019-03-31	110,726	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	7,405,253	USD	365
2017-04-01 to 2018-03-31	76,536,315	USD	365
2016-04-01 to 2017-03-31	10,093,075	USD	365

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	5,532,581	USD	365
2017-04-01 to 2018-03-31	65,510,625	USD	365
2016-04-01 to 2017-03-31	8,570,864	USD	365

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	-603,606	USD	365
2017-04-01 to 2018-03-31	71,405,954	USD	365
2016-04-01 to 2017-03-31	7,490,828	USD	365

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	5,532,581	USD	365
2017-04-01 to 2018-03-31	65,481,973	USD	365
2016-04-01 to 2017-03-31	8,570,864	USD	365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	9,928,512	USD	365
2017-04-01 to 2018-03-31	5,816,130	USD	365
2016-04-01 to 2017-03-31	2,645,605	USD	365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	406,799	USD	365
2017-04-01 to 2018-03-31	174,384	USD	365
2016-04-01 to 2017-03-31	92,224	USD	365

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	2,307,485	USD	365
2017-04-01 to 2018-03-31	660,877	USD	365
2016-04-01 to 2017-03-31	179,529	USD	365

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	5,596,753	USD	365
2017-04-01 to 2018-03-31	10,610,067	USD	365
2016-04-01 to 2017-03-31	1,386,570	USD	365

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2018-04-01 to 2019-03-31	-3,724,081	USD	365
2017-04-01 to 2018-03-31	415,623	USD	365
2016-04-01 to 2017-03-31	135,641	USD	365

Inspect the source

Entity: Akso Health Group / CIK 0001702318
Captured: 2026-09-21T17:25:55.471Z
SEC response SHA-256: 3745e2e028c3e1db84b9dfc8559d2a42141cc5ccfce0611c3869cdb9e1041455

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001702318.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))